Mariner
KURA icon

Mariner’s Kura Oncology KURA Stock Holding History

Mariner’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
148,257
+55,446
+60% +$523K ﹤0.01% 1622
2026
Q1 		$754K Sell
92,811
-33,109
-26% -$284K ﹤0.01% 2169
2025
Q4 		$1.31M Buy
125,920
+63,907
+103% +$671K ﹤0.01% 1759
2025
Q3 		$549K Buy
62,013
+51,256
+476% +$365K ﹤0.01% 2356
2025
Q2 		$62.1K Sell
10,757
-5,857
-35% -$35.9K ﹤0.01% 3316
2025
Q1 		$110K Buy
+16,614
New +$129K ﹤0.01% 3170

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Mariner's KURA Position: Q2 2026 in Review

Mariner increased its Kura Oncology (KURA) stake by 60% in Q2 2026, buying an estimated $523K and bringing the position to 148,257 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Mariner first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Mariner held 148,257 shares of Kura Oncology worth $1.63M as of Q2 2026.
  • Mariner bought 55,446 Kura Oncology shares in Q2 2026, an estimated $523K.
  • Kura Oncology made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1622 holding.
  • Mariner first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.